Promontory Therapeutics Awarded Cancer Immunology Solution of the Year in 2022 BioTech Breakthrough Awards Program

New York, NY (PRWEB) November 03, 2022 -- Promontory Therapeutics Inc., a clinical stage biotech company advancing small molecule immunotherapies in oncology,

Related Keywords

United States ,China ,Germany ,Canada ,Robert Fallon ,Bryan Vaughn ,Pfizer ,Merck Kga ,Promontory Therapeutics Inc ,National Cancer Institute ,Merck Kgaa ,Serono ,Biotech Breakthrough ,Promontory President ,Chief Executive ,Therapeutics Inc ,Immunology Solution ,Biotech Breakthrough Awards ,Chief Executive Officer Robert ,Managing Director ,Cancer Immunology Solution ,Clinical Medicine ,Promontory Therapeutics ,Orphan Drug ,Tech Breakthrough ,Food Science ,Press Release ,